arrow
M

Marcin Milchert

department of internal medicine
H指数:16
被引数:1,143

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Mental- and physical-health comorbidity are strongly associated in idiopathic inflammatory myopathies: a multinational cross-sectional e-survey

特发性炎症性肌病中心理和生理健康共病存在强关联:一项跨国横断面电子调查

2026-08-290
OAAI
Defining age-related thresholds in hand, wrist, and foot ultrasound: an international, cross-sectional, observational study by the Outcome Measures in Rheumatology Ultrasound Working Group

定义手、腕和足部超声的年龄相关阈值:风湿病学超声工作组进行的一项国际性、横断面、观察性研究

2026-08-140
PRE
Global inequities in biologic and targeted DMARD use in rheumatoid arthritis: cross-sectional data from the international COVAD-2 cohort

类风湿关节炎中生物制剂和靶向合成改善病情抗风湿药使用的全球不平等现象:国际COVAD-2队列的横断面数据

2026-05-130
PRE
Discordance in Patient and Physician's Perception of Disease Activity Among Idiopathic Inflammatory Myopathy Patients: Insights From the COVAD Study

特发性炎症性肌病患者与医师对疾病活动度的感知差异:来自COVAD研究的见解

2025-10-010
PRE
American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert Panel

美国风湿病学会关于VEXAS诊断与管理的指南声明,由国际VEXAS工作组专家委员会制定

2025-08-110
OAAI
Clinical significance of the anti-Nucleolar Organizer Region 90 antibodies (NOR90) in systemic sclerosis: Analysis of the European Scleroderma Trials and Research (EUSTAR) cohort and a systematic literature review
2024-07-015
PRE
IDENTIFICATION OF ANCA-ASSOCIATED VASCULITIS RELAPSE RISK FACTORS FOR BUILDING A PERSONALIZED MAINTENANCE THERAPY SCHEME MODEL

ANCA相关性血管炎复发的风险因素识别:构建个性化维持治疗方案模型

2024-06-010
PRE
THE IMPACT OF MENTAL HEALTH COMORBIDITIES ON QUALITY OF LIFE IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES: A COVAD-2 STUDY

特发性炎症性肌病患者中精神健康共病对生活质量的影响:一项COVAD-2研究

2024-06-010
PRE
Clinical Characteristics of EGPA Patients in Comparison to GPA Subgroup with Increased Blood Eosinophilia from POLVAS Registry
2024-04-252
OA
Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time?
2023-12-112
OA
Delayed adverse events following COVID-19 vaccination in patients with systemic sclerosis and other autoimmune diseases: a substudy of the COVAD-2 cohort

系统性硬化症和其他自身免疫性疾病患者新型冠状病毒肺炎疫苗接种后的延迟不良事件: COVAD-2队列的一项子研究

2023-09-152
PRE
Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey

系统性硬化症接种疫苗患者突破性新型冠状病毒肺炎的相关性: 来自多中心国际患者报告调查的生存分析

2023-09-053
PRE
Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study

特发性炎性肌病患者接种COVID疫苗的长期安全性: 来自COVAD研究的结果

2023-06-238
OAAI
High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey
2023-06-145
OAAI
Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey

系统性硬化症和新型冠状病毒肺炎疫苗安全性: 全球自身免疫性疾病新型冠状病毒肺炎疫苗接种 (COVAD) 调查的短期见解

2023-03-317
OAAI
COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey

特发性炎性肌病、其他系统性自身免疫和炎性疾病以及健康对照的新型冠状病毒肺炎严重程度和疫苗突破性感染: 来自自身免疫性疾病新型冠状病毒肺炎疫苗接种 (COVAD) 调查的多中心横断面研究

2022-10-2213
OAAI
COVID-19 in unvaccinated patients with inborn errors of immunity-polish experience
2022-09-2310
OAAI